Clinical trial
Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach
NCT05894915 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach
- Lead sponsor
- Peking University People's Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 390 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial carcinoma, tumor molecular features screening model